BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14994969)

  • 1. Pathogenesis of breast carcinoma.
    Fentiman IS; D'Arrigo C
    Int J Clin Pract; 2004 Jan; 58(1):35-40. PubMed ID: 14994969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign breast diseases, carcinoma in situ, and breast cancer risk.
    Bodian CA
    Epidemiol Rev; 1993; 15(1):177-87. PubMed ID: 8405202
    [No Abstract]   [Full Text] [Related]  

  • 3. Histopathologic risk factors for breast cancer in women with benign breast disease.
    Page DL; Dupont WD
    Semin Surg Oncol; 1988; 4(4):213-7. PubMed ID: 2854655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic considerations in the high-risk breast patient.
    Simmons R; Serafin D; McCarty K
    Clin Plast Surg; 1988 Oct; 15(4):655-65. PubMed ID: 2852084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign breast disease. Resolved and unresolved issues.
    Connolly JL; Schnitt SJ
    Cancer; 1993 Feb; 71(4):1187-9. PubMed ID: 8382102
    [No Abstract]   [Full Text] [Related]  

  • 7. Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ.
    Sneige N; Staerkel GA
    Hum Pathol; 1994 May; 25(5):485-92. PubMed ID: 8200642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillomas of the breast. A histologic spectrum including atypical hyperplasia and carcinoma in situ.
    McKinney CD; Fechner RE
    Pathol Annu; 1995; 30 Pt 2():137-78. PubMed ID: 8570274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower-category benign breast disease and the risk of invasive breast cancer.
    Wang J; Costantino JP; Tan-Chiu E; Wickerham DL; Paik S; Wolmark N
    J Natl Cancer Inst; 2004 Apr; 96(8):616-20. PubMed ID: 15100339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization by image cytometry of duct epithelial proliferative disease of the breast.
    King EB; Chew KL; Hom JD; Duarte LA; Mayall B; Miller TR; Neuhaus JM; Wrensch MR; Petrakis NL
    Mod Pathol; 1991 May; 4(3):291-6. PubMed ID: 1712475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of atypical lobular hyperplasia, atypical ductal hyperplasia, and lobular carcinoma in situ.
    Clauser P; Marino MA; Baltzer PA; Bazzocchi M; Zuiani C
    Expert Rev Anticancer Ther; 2016; 16(3):335-46. PubMed ID: 26780850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The breast: tissue changes and cancer risk.
    Sinclair RA
    Med J Aust; 1988 Oct; 149(8):424-6. PubMed ID: 3173205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large duct epithelial hyperplasia and carcinoma of the breast.
    Humphrey LJ; Swerdlow MA
    Arch Surg; 1968 Oct; 97(4):592-4. PubMed ID: 5678126
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy.
    Neal L; Sandhu NP; Hieken TJ; Glazebrook KN; Mac Bride MB; Dilaveri CA; Wahner-Roedler DL; Ghosh K; Visscher DW
    Mayo Clin Proc; 2014 Apr; 89(4):536-47. PubMed ID: 24684875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A follow-up study about 52 cases of atypical lobular hyperplasia and lobular carcinoma in situ of the breast].
    Li HY; Ren GS; Arnould N; Brettes JP
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):874-6. PubMed ID: 17953828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
    Piubello Q; Montemezzi S; D'Atri C
    Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of flat epithelial atypia (FEA) after stereotactic vacuum-assisted biopsy (VAB) of the breast: What is the best management: systematic surgery for all or follow-up?].
    David N; Labbe-Devilliers C; Moreau D; Loussouarn D; Campion L
    J Radiol; 2006 Nov; 87(11 Pt 1):1671-7. PubMed ID: 17095961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of benign proliferative breast disease.
    Bodian CA; Perzin KH; Lattes R; Hoffmann P; Abernathy TG
    Cancer; 1993 Jun; 71(12):3896-907. PubMed ID: 8389654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperplastic lesions of the human breast: scanning electron microscopy and a review of current knowledge.
    Halter SA; Holt DH; Page DL
    Scan Electron Microsc; 1981; (Pt 3):11-21. PubMed ID: 6276966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.